[2-O] Oral Presentation

9:30 AM - 9:45 AM JST(12:30 AM - 12:45 AM UTC)

[2-O-09] Development of a novel anti-CD44 variant 4 monoclonal antibody, C44Mab-108

*Kai Shimizu¹, Hiroyuki Suzuki², Mika Kaneko², Yukinari Kato² (1. Tohoku University School of Medicine, 2. Tohoku University Graduate School of Medicine)

Keywords:

antibody,cancer,tumor marker

Password required to view

Enter the password to view the abstracts.
The password will be emailed to those who have completed the registration.